Litcius/Paper detail

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data

Alisa Stöber, Johanna I. Lutter, Larissa Schwarzkopf, F.W. Kirsch, Anja Schramm, Claus Vogelmeier, Reiner Leidl

2021International Journal of COPD19 citationsDOIOpen Access PDF

Abstract

Purpose: Real-world evidence on the impact of forced expiratory volume in one second (FEV 1 ) and exacerbations on health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) is sparse especially with regard to GOLD ABCD groups. This study investigates how changes in FEV 1 and exacerbations affect generic and disease-specific HRQoL in COPD patients over one year. Methods: Using German claims data and survey data, we classified 3016 COPD patients and analyzed their health status by GOLD groups AB and CD. HRQoL was measured with the disease-specific COPD assessment test (CAT) and the visual analog scale (VAS) from the generic Euro-Qol 5D-5L. We applied change score models to assess associations between changes in FEV 1 (≥ 100 mL decrease/no change/≥ 100 mL increase) or the development of severe exacerbations with change in HRQoL. Results: FEV 1 decrease was associated with a significant but not minimal important difference (MID) deterioration in disease-specific HRQoL (mean change [95% CI]: CAT +0.74 [0.15 to 1.33]), while no significant change was observed in the generic VAS. Experiencing at least one severe exacerbation also had a significant impact on CAT deterioration (+1.58 [0.52 to 2.64]), but again not on VAS. Here, GOLD groups AB showed not only a statistically but also a clinically relevant MID deterioration in CAT (+2.1 [0.88 to 3.32]). These particular patient groups were further characterized by a higher probability of being male, having a higher mMRC and Charlson index, and a lower probability of having higher FEV 1 or BMI values. Conclusion: FEV 1 decline and the occurrence of ≥ 1 severe exacerbation are significantly associated with overall deterioration in disease-specific HRQoL. Preventing severe exacerbations particularly in patients without previous severe exacerbations (ABCD groups A and B) may help to stabilize the key patient-reported outcome HRQoL. Keywords: COPD, health-related quality of life, longitudinal study, real-world evidence, forced expiratory volume in 1 second, exacerbation

Topics & Concepts

MedicineCOPDExacerbationQuality of life (healthcare)Obstructive lung diseaseVisual analogue scaleMinimal clinically important differenceHealth related quality of lifePulmonary function testingInternal medicineLung functionEQ-5DGold standard (test)Pulmonary diseaseDiseasePhysical therapyLungRandomized controlled trialNursingChronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesDelphi Technique in Research